Sign in

You're signed outSign in or to get full access.

Steven Strandberg

Director at Crescent Capital BDC
Board

About Steven F. Strandberg

Steven F. Strandberg (born 1955) is an Independent Director of Crescent Capital BDC, Inc. (CCAP), serving since 2015; he is Class III with a term expiring in 2027 and is Chairman of the Compensation Committee as well as a member of the Audit and Nominating & Corporate Governance Committees . He is co‑founder and Managing Partner of Albany Road Real Estate Partners; previously he co‑founded WestBridge Ventures and led Merrill Lynch’s West Coast Technology Investment Banking group after roles at Donaldson, Lufkin & Jenrette and Morgan Stanley . He holds an M.B.A. from Harvard University and an A.B. from the University of Chicago .

Past Roles

OrganizationRoleTenureCommittees/Impact
WestBridge VenturesManaging Director & Co‑founderNot disclosedLater-stage private technology investing
Merrill LynchFounder & Head, West Coast Technology Investment BankingNot disclosedLed coverage/advisory for emerging private companies
Donaldson, Lufkin & JenretteInvestment BankingNot disclosedAdvisory roles
Morgan StanleyInvestment BankingNot disclosedAdvisory roles

External Roles

OrganizationRoleTenureNotes
Albany Road Real Estate PartnersCo‑founder & Managing PartnerNot disclosedReal estate investment leadership
Other public company boards (past 5 years)NoneNone disclosed in CCAP proxy
CCAP Fund Complex oversight1 portfolio companyCurrentOversees CCAP only within fund complex

Board Governance

  • Committee assignments: Chairman of the Compensation Committee; member of Audit and Nominating & Corporate Governance Committees .
  • Independence: CCAP’s Board has five Independent Directors; Strandberg is listed as an Independent Director under Nasdaq Rule 4200(a)(15) .
  • Lead Independent Director: CCAP does not designate a lead Independent Director given board size and structure .
  • Attendance and meetings: In 2024, Board held 5 meetings; Audit 4; Nominating 2; Compensation 1; all Directors attended at least 75% of Board and committee meetings held while members .
  • Term and class: Class III Director since 2015; current term expires in 2027 .

Fixed Compensation

  • CCAP Independent Director fee schedule (2024): $105,000 annual fee; $2,500 per regular Board meeting; $1,000 per special Board meeting; $1,000 per committee meeting; Audit Chair receives $12,500; Compensation Chair $5,000; Nominating Chair $5,000 .
  • CCAP Independent Director fee schedule (2023): $95,000 annual fee; same meeting fees; Audit Chair $10,000 increased to $12,500 after August 3, 2023; Compensation Chair $5,000; Nominating Chair $5,000 .
Metric (USD)FY 2023FY 2024
Aggregate Compensation from CCAP$116,000 $122,000
Compensation Chair fee (included above)$5,000 $5,000

Performance Compensation

  • Independent directors receive cash fees and meeting/committee chair fees; no performance-based metrics or equity awards are disclosed for directors in CCAP’s proxy .
Performance MetricFY 2023FY 2024
TSR/EBITDA/Revenue targetsNot applicable (no director performance pay disclosed) Not applicable (no director performance pay disclosed)
RSUs/PSUs/Options (director)Not disclosed Not disclosed

Other Directorships & Interlocks

CompanyRolePeriodNotes
Public company boards (past 5 years)NoneNone disclosed
CCAP Fund Complex (CPCI, CCS IX BDC)NoneCurrentStrandberg oversees only 1 portfolio company (CCAP) in the Fund Complex

Expertise & Qualifications

  • Financial markets and board experience across real estate and technology; venture and later-stage private tech investing .
  • Senior investment banking leadership (M&A and financing) at major firms; operational oversight through multiple board roles .
  • Education: M.B.A., Harvard University; A.B., University of Chicago .

Equity Ownership

  • CCAP’s Code of Ethics and Insider Trading Policy prohibit hedging, short sales, margin accounts, pledging of CCAP stock, and derivative transactions by Directors, supporting alignment with shareholders .
Ownership MetricAs of Mar 13, 2024 (Record Date)As of Mar 19, 2025 (Record Date)
Shares beneficially owned245,108 256,357
% of shares outstanding0.66% 0.69%
Dollar range of CCAP equityOver $100,000 Over $100,000

Insider Trades

Note: We attempted to retrieve Form 4 transactions via the insider-trades skill for “Strandberg” at CCAP from 2023-01-01 to 2025-11-19, but the data source returned an authorization error; therefore, specific trade details are not available in this report.

  • Section 16(a) compliance: CCAP reported that Directors and Officers complied with filing requirements for FY 2023 (no delinquent reports) .

Related Party Transactions & Conflicts

  • Pre‑Board investments: Prior to serving on the Board, Strandberg invested in private funds managed by an affiliate of the Advisor; to avoid conflicts, he is excluded from the “required majority” votes on co‑investments alongside those funds, and he has not added capital post‑service except to satisfy pre‑existing commitments .
  • Fee treatment: His pre‑existing fund investments are not subject to management fees typically charged to other investors, which is disclosed and managed via governance protocols .
  • Co‑investment oversight: CCAP operates under SEC exemptive relief for co‑investments; a required majority of Independent Directors must conclude terms are fair and consistent with shareholder interests .

Governance Assessment

  • Alignment: Strandberg’s sizable personal stake (256,357 shares; 0.69% of outstanding) indicates meaningful alignment with shareholders, and CCAP’s prohibition of hedging/pledging strengthens alignment safeguards .
  • Engagement: Chairing Compensation and serving on Audit and Nominating suggests high engagement; attendance thresholds were met across meetings in 2024 .
  • Independence: Classified as an Independent Director; CCAP maintains a majority of Independent Directors and committee chairs are independent .
  • Conflicts: Pre‑Board fund investments introduce potential conflict; however, CCAP’s exclusion of Strandberg from required‑majority co‑investment approvals and disclosure of fee treatment are mitigating controls .
  • Board structure: Absence of a Lead Independent Director may limit coordination benefits, though CCAP cites small board size and independent committee chairs as offsetting factors .

RED FLAGS

  • Pre‑existing investments with an affiliate of the Advisor represent potential perceived conflicts, albeit with explicit mitigations (exclusion from required‑majority votes; no additional capital; fee treatment disclosure) .
  • No lead Independent Director designated, which some investors view as a governance gap despite CCAP’s rationale .